Imaging Exploration of Molecular Subtypes in Tongue Squamous Cell Carcinoma

Hao Pan; Peipei Wang; Yajie Chang; Bingyi Lu; Yunyan Jiang; Mengfan Wang; Xinyue Wang; Xinrou Yang; Jiyuan Zhang; Yu Liu; Andrei Velichko; Yuanjun Wang

arXiv · 2604.23679

Imaging Exploration of Molecular Subtypes in Tongue Squamous Cell Carcinoma

Hao Pan·Peipei Wang·Yajie Chang·Bingyi Lu·Yunyan Jiang·Mengfan Wang·Xinyue Wang·Xinrou Yang·Jiyuan Zhang·Yu Liu·Andrei Velichko·Yuanjun Wang

View original source ↗Read source document ↗Export metadata ↓

Abstract

Tongue squamous cell carcinoma (TSCC) is an aggressive malignancy with marked biological heterogeneity and variable clinical outcomes. Although molecular profiling has improved understanding of TSCC heterogeneity, its clinical use remains constrained by invasive tissue sampling and limited representation of whole-tumor spatial complexity. Meanwhile, most radiomics studies in TSCC have focused on downstream clinical endpoints, and whether imaging can non-invasively reflect intrinsic molecular subtypes remains unclear. In this study, an integrated transcriptomic-radiomics framework was used to investigate the relationship between preoperative imaging phenotypes and molecular subtypes in TSCC. Transcriptomic data from 60 TSCC cases in The Cancer Genome Atlas were analyzed using unsupervised consensus clustering, followed by differential expression and functional enrichment analyses. Matched preoperative imaging data from The Cancer Imaging Archive were manually annotated for primary tumor regions, and radiomic features were extracted using PyRadiomics; group differences were assessed with the U-test. Two stable molecular subtypes, C1 and C2, were identified. Their biological differences were mainly associated with squamous epithelial differentiation, inflammatory signaling, and lipid metabolism, with C2 showing greater enrichment of immune-related pathways. In addition, 10 radiomic features differed significantly between the two subtypes, mainly wavelet-derived texture features from gray-level size zone, dependence, co-occurrence, and run length matrices (P=0.00202-0.0162). These findings support the potential of radiomics as a non-invasive approach for characterizing molecular heterogeneity in TSCC and provide an initial radiogenomic framework for biologically informed preoperative assessment.

Explore related subjects

q-bio.GN

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Hao Pan, Peipei Wang, Yajie Chang, Bingyi Lu, Yunyan Jiang, Mengfan Wang, Xinyue Wang, Xinrou Yang, Jiyuan Zhang, Yu Liu, Andrei Velichko, Yuanjun Wang. 2026-04-26. Imaging Exploration of Molecular Subtypes in Tongue Squamous Cell Carcinoma. https://arxiv.org/abs/2604.23679

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

arXiv2026

Transcriptomic Models for Immunotherapy Response Prediction Show Limited Cross-cohort Generalisability

Immune checkpoint inhibitors (ICIs) have transformed cancer therapy; yet substantial proportion of patients exhibit intrinsic or acquired resistance, making accurate pre-treatment response prediction a critical unmet need. Transcriptomics-based biomarkers derived from bulk and single-cell RNA sequencing (scRNA-seq) offer a promising avenue for capturing tumour-immune interactions, yet the cross-cohort generalisability of existing prediction models remains unclear.We systematically benchmark nine state-of-the-art transcriptomic ICI response predictors, five bulk RNA-seq-based models (COMPASS, IRNet, NetBio, IKCScore, and TNBC-ICI) and four scRNA-seq-based models (PRECISE, DeepGeneX, Tres and scCURE), using publicly available independent datasets unseen during model development. Overall, predictive performance was modest: bulk RNA-seq models performed at or near chance level across most cohorts, while scRNA-seq models showed only marginal improvements. Pathway-level analyses revealed sparse and inconsistent biomarker signals across models. Although scRNA-seq-based predictors converged on immune-related programs such as allograft rejection, bulk RNA-seq-based models exhibited little reproducible overlap. PRECISE and NetBio identified the most coherent immune-related themes, whereas IRNet predominantly captured metabolic pathways weakly aligned with ICI biology. Together, these findings demonstrate the limited cross-cohort robustness and biological consistency of current transcriptomic ICI prediction models, underscoring the need for improved domain adaptation, standardised preprocessing, and biologically grounded model design.

q-bio.GN↗

arXiv2026

Large Language Model Agents for Evidence Based Genetic Disease Severity Classification

Disease severity classification for genetic conditions is subjective and labor-intensive, creating bottlenecks in genomic screening, where commercial panels vary widely in size and overlap. We developed an autonomous AI agent integrating Reasoning and Acting (ReAct) with Retrieval-Augmented Generation (RAG) to classify 10,211 Human Phenotype Ontology terms. It uses American College of Medical Genetics (ACMG)-endorsed severity guidelines and American College of Obstetricians and Gynecologists (ACOG) quality-of-life criteria to retrieve PubMed literature, generate interpretable reasoning chains, and independently verify claims. At the phenotype level, using expert-curated cohorts, the agent achieved 93.55% accuracy (MCC 0.9237) with 82.6% to 91.4% of claims supported by direct evidence or valid inferences. Gene-level severity was aggregated across 8,738 pairs, identifying 3,283 autosomal recessive pairs with severe or profound presentations. External validation showed 95.2% concordance with Mackenzie's Mission gene list. This system enables standardized panel design by providing reliable, automated classification supported by direct evidence.

q-bio.GN↗

arXiv2026

Harmonised benchmarking of foundation models for single-cell and spatial transcriptomics reveals context-dependent generalisation

Single-cell and spatial foundation models promise transferable biological representations, yet their generality remains largely untested across modalities, biological domains and analytical tasks. We benchmarked six representative models, Nicheformer, CellPLM, scGPT-spatial, GenePT, scELMo and Novae, using a harmonised framework spanning scRNA-seq, spatial transcriptomics and Perturb-seq. We evaluated zero-shot and continually pretrained clustering, supervised annotation, marker-gene concordance and perturbation prediction. Model performance was strongly conditional: expression-trained cell-level transformers best resolved many cell-identity tasks, spatial and graph-aware models better preserved tissue architecture, and language-derived gene embeddings were competitive for selected perturbation-response metrics. No model dominated across tasks, and rankings shifted with modality, preprocessing, tokenisation, biological prior, domain shift and metric choice. This benchmark provides practical guidance for model selection and argues that future models should be judged by biological generalisation, interpretability and perturbation-grounded validity, not by scale or leaderboard performance alone.

q-bio.GN↗